NCT05263245View on ClinicalTrials.gov

The Pharmacological Effects of Using Cabozantinib With a Light Breakfast

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

May 25, 2023

Primary Completion Date

March 11, 2025

Study Completion Date

March 11, 2025

Conditions
Renal Cell Carcinoma
Interventions
OTHER

Light breakfast

Light breakfast, standardized by 7 menu options for patients. All breakfast options contain the same amount of fat (9-10 g). Example of a menu: 150 ml full-fat yoghurt, 40 gram muesli with sugar, 1 glass of tea.

Trial Locations (2)

2333 ZA

Leids Universitair Medisch Centrum, Leiden

3015 GD

Erasmus Medical Center, Rotterdam

All Listed Sponsors
collaborator

Leiden University Medical Center

OTHER

lead

dr. Tom van der Hulle

OTHER

NCT05263245 - The Pharmacological Effects of Using Cabozantinib With a Light Breakfast | Biotech Hunter | Biotech Hunter